What Canopy Growth (CGC) Investors Need to Know

By Tamara Parker • Thursday, June 01 12:19 • Permanent Link

Join us for a quick overview of Canopy Growth, a Medicinal Chemicals company whose shares moved 0.5% today. Here are some facts about the stock that should help you see the bigger picture:

Canopy Growth has moved -82.3% over the last year, and the S&P 500 logged a change of 0.1%
CGC has an average analyst rating of underperform and is -44.4% away from its mean target price of $1.51 per share
Its trailing earnings per share (EPS) is $-5.08
Canopy Growth has a trailing 12 month Price to Earnings (P/E) ratio of -0.2 while the S&P 500 average is 15.97
Its forward earnings per share (EPS) is $-0.54 and its forward P/E ratio is -1.6
The company has a Price to Book (P/B) ratio of 0.29 in contrast to the S&P 500's average ratio of 2.95
Canopy Growth is part of the Health Care sector, which has an average P/E ratio of 24.45 and an average P/B of 4.16
The company has a free cash flow of $-103817752, which refers to the total sum of all its inflows and outflows of cash over the last quarter
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.